Bg pattern

REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Remifentanilo Kern Pharma 5 mg powder for concentrate for solution for injection and infusion EFG

Remifentanilo

Read all of this leaflet carefully before you start taking this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others, as it may harm them, even if their symptoms are the same as yours.
  • If you experience any of the side effects, inform your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Contents of the package leaflet:

  1. What is Remifentanilo Kern Pharma and what is it used for
  2. What you need to know before taking Remifentanilo Kern Pharma
  3. How to take Remifentanilo Kern Pharma
  4. Possible side effects
  5. Storage of Remifentanilo Kern Pharma
  6. Contents of the pack and further information

1. What is Remifentanilo Kern Pharma and what is it used for

Remifentanilo is an anaesthetic that belongs to a group of medicines called opioids (substances that have an action similar to morphine in the body).

This medicine is used:

  • to help you sleep before an operation,
  • to keep you asleep and prevent you from feeling pain during the operation,
  • to stop you feeling pain while you are being treated in the Intensive Care Unit.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Remifentanilo Kern Pharma

Do not take Remifentanilo Kern Pharma

  • if you are allergic (hypersensitive) to remifentanilo or any of the other ingredients,
  • if you are allergic (hypersensitive) to other opioid medicines, such as morphine,
  • if it is used as the only drug to induce anaesthesia.

Because the formulation includes glycine, remifentanilo must not be given for epidural or intrathecal use (injection into the area around the spine or into the cerebrospinal fluid).

Be careful with Remifentanilo Kern Pharma

Before starting treatment with Remifentanilo Kern Pharma, tell your doctor:

  • you or a family member have ever abused or been dependent on alcohol, prescription medicines or illegal drugs ("addiction").
  • you are a smoker.
  • you have ever had mood problems (depression, anxiety or personality disorder) or have been treated by a psychiatrist for other mental illnesses.
  • if you have had any breathing problems (respiratory problems),
  • if you have severe heart problems (heart failure),
  • if you have been told you have low blood pressure (hypotension),
  • if you have had severe liver problems (liver failure),
  • if you feel weak or have suffered a decrease in blood volume (hypovolemia). You should also be careful if you are an elderly person.

While being treated with Remifentanilo Kern Pharma:

  • As with other morphine-like medicines, you may experience:
  • breathing problems (breathing too shallow or too slow),
  • muscle stiffness. This effect depends on the dose and speed of administration. For this reason, when administered in a vein as a single slow injection (in a single bolus), Remifentanilo Kern Pharma should not be administered in less than 30 seconds.
  • low blood pressure (hypotension) or slow heart rate (bradycardia).

If this happens, your doctor will give you specific and appropriate treatment. Your doctor will adjust the dose you are being given and the speed of administration.

Your doctor will make sure you have recovered satisfactorily before allowing you to leave the recovery room.

  • Remifentanilo has a rapid offset of action. There will be no residual analgesic activity within 5 to 10 minutes after stopping administration. During operations that are known to be painful, analgesics should be administered before stopping remifentanilo administration.

You should be allowed sufficient time to ensure that longer-acting analgesics are effective. These analgesics should be chosen based on the type of surgery and the level of postoperative monitoring.

This medicine contains remifentanilo which is an opioid. Repeated use of opioids can make the medicine less effective (you get used to its effect). It can also cause dependence and abuse, which can lead to a potentially life-threatening overdose. If you are concerned that you may become dependent on remifentanilo, it is important that you consult your doctor.

Ocasional reports of withdrawal reactions (e.g. rapid heartbeat, high blood pressure and agitation) have been reported after sudden stop of treatment with this medicine, especially when treatment was given for more than 3 days (see also section 4. Possible side effects). If you experience these symptoms, your doctor may restart treatment with the medicine and gradually reduce the dose.

Use of other medicines

Tell your doctor or pharmacist if you are using or have recently used other medicines, including those obtained without a prescription.

This is because remifentanilo can interact with other medicines and cause side effects.

In particular, tell your doctor or pharmacist if you are taking medicines for your heart or blood pressure, such as beta-blockers or calcium channel blockers, or medicines to induce sleep, reduce anxiety or relax muscles, belonging to a group of agents called benzodiazepines or medicines to treat depression, such as selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs) and monoamine oxidase inhibitors (MAOIs). It is not recommended to use these medicines at the same time as remifentanilo, as they may increase the risk of serotonin syndrome, a potentially life-threatening condition. Concomitant use of remifentanilo and sedative medicines such as benzodiazepines or related medicines increases the risk of drowsiness, breathing difficulties (respiratory depression), coma and can be life-threatening. Therefore, concomitant use should only be considered when no other treatment options are possible. Concomitant use of opioids and other medicines used to treat epilepsy, nerve pain or anxiety (gabapentin and pregabalin) increases the risk of opioid overdose and respiratory depression, and can be potentially life-threatening.

However, if your doctor prescribes remifentanilo with sedative medicines, the dose and duration of concomitant treatment should be limited by your doctor.

Tell your doctor about all sedative medicines you are taking and follow your doctor's recommendations regarding the dose carefully. It may be useful to inform friends or family members so they are aware of the signs and symptoms mentioned above. Contact your doctor when you experience such symptoms.

Pregnancy and breastfeeding

Tell your doctor if you are pregnant or planning to become pregnant or breastfeed.

Generally, this medicine should not be used during pregnancy, unless your doctor tells you to do so.

You should not breastfeed during the 24 hours following administration of remifentanilo.

There is not enough data to recommend the use of remifentanilo during labour and delivery.

Ask your doctor or pharmacist for advice before taking any medicine.

If you receive this medicine during labour or shortly before delivery, it may affect your baby's breathing. You and your baby will be monitored for signs of excessive sleepiness or breathing difficulties.

Driving and using machines

Do not drive or use tools or machines after receiving this medicine, as it may affect your ability to react. Your doctor will tell you how long you should wait before driving or using machines again.

Athletes

Athletes should be careful as this medicine contains an active substance that may give a positive result in doping control.

3. How to take Remifentanilo Kern Pharma

You will never give yourself this medicine. This medicine will always be given by qualified personnel and under carefully controlled conditions.

Dose

The dose you receive will depend on:

  • the operation,
  • how much pain relief you need.

Doses vary from patient to patient. It depends on your age, body weight and general condition.

Your doctor will decide the dose that is right for you. He/she will adjust it according to the effect obtained during anaesthesia.

Method of administration

This medicine will be given to you by injection into a vein.

Remifentanilo can be given:

  • as a single injection into your vein (injection in bolus),
  • as a continuous infusion into your vein. This is when the medicine is given slowly over a long period of time.

Special care should be taken to avoid any accidental administration, especially at the end of anaesthesia.

Duration of treatment

Your doctor will decide the duration of therapy that is right for you and your operation.

Remifentanilo should not be used in intensive care patients with mechanical ventilation for more than 3 days.

If you take more Remifentanilo Kern Pharma than you should

Your doctor will take immediate action.

If you stop treatment with Remifentanilo Kern Pharma

Like other morphine-like medicines, this medicine can cause dependence.

Ask your doctor or pharmacist if you have any questions about the use of this medicine.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Remifentanilo Kern Pharma can cause side effects, although not everybody gets them.

Very common side effects (affect more than 1 in 10 people)

  • muscle stiffness – please also see section 2,
  • low blood pressure (hypotension) - please also see section 2,
  • nausea, vomiting.

Common side effects (affect 1 to 10 people in 100)

  • slow heart rate (bradycardia) - please also see section 2,
  • postoperative increase in blood pressure (hypertension),
  • breathing problems (breathing too shallow or too slow) - please also see section 2, pauses in breathing (apnea),
  • itching (pruritus),
  • postoperative shivering.
  • cough

Uncommon side effects (affect 1 to 10 people in 1,000)

  • lack of oxygen in the blood (hypoxia),
  • constipation,
  • postoperative pain.

Rare side effects (affect 1 to 10 people in 10,000)

  • in patients receiving remifentanilo together with one or more anaesthetic medicines, allergic reactions have been detected, including acute allergic hypersensitivity reaction (anaphylaxis),
  • feeling sleepy (sedation) during recovery from general anaesthesia,
  • in patients receiving remifentanilo together with other anaesthetic medicines, cardiac arrest has been detected, usually preceded by a slow heart rate (bradycardia).

Side effects of unknown frequency

  • withdrawal syndrome (may manifest with the following side effects: increased heart rate, high blood pressure, feeling of agitation or restlessness, nausea, vomiting, diarrhoea, anxiety, chills, shivering and sweating)
  • irregular heartbeat (arrhythmia)

If you experience any of the side effects, inform your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Remifentanilo Kern Pharma

Keep this medicine out of the sight and reach of children.

Do not use remifentanilo after the expiry date stated on the carton and vial. The expiry date is the last day of the month stated.

Do not store above 30°C.

Chemical and physical stability of the reconstituted solution has been demonstrated for 24 hours at 25°C.

Chemical and physical stability of the diluted solution has been demonstrated for 4 hours at 25°C.

From a microbiological point of view, the product should be used immediately. If not used immediately, the storage times and conditions are the responsibility of the user and normally should not exceed 24 hours at 2-8°C, unless the reconstitution/dilution has been made in controlled and validated aseptic conditions.

Do not use Remifentanilo Kern Pharma if you notice any signs of deterioration after reconstitution.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Container Content and Additional Information

Composition of Remifentanilo Kern Pharma

  • The active ingredient is remifentanil. Each vial contains 5 mg of remifentanil (as hydrochloride).

After reconstitution, the solution contains 1 mg/ml of remifentanil (as hydrochloride), if prepared as recommended.

  • The other components are: glycine and hydrochloric acid 37% (for pH adjustment).

Appearance of Remifentanilo Kern Pharma and Container Content

Remifentanil is a white or off-white powder for concentrate for solution for injection and infusion.

Packaging of 5 vials.

Marketing Authorization Holder

Kern Pharma, S.L.

Venus, 72 - Pol. Ind. Colón II

08228 Terrassa - Barcelona

Spain

Manufacturer

Laboratorio Reig Jofré, S.A.

Gran Capitán 10

08970 Sant Joan Despí (Barcelona)

Spain

This leaflet was last revised in May 2022

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

<---------------------------------------------------------------------------------------------------------------->

This information is intended exclusively for healthcare professionals:

Remifentanilo Kern Pharma 5 mg powder for concentrate for solution for injection and infusion

Handling and Use Instructions

This medication must be reconstituted by adding 5 ml of solution for injection to obtain a reconstituted solution with a remifentanil concentration of approximately 1 mg/ml.

After reconstitution, the solution should not be administered as is, but rather diluted again.

For manually performed infusions, remifentanil can be diluted to concentrations ranging from 20 to 250 micrograms/ml (the recommended dilution is 50 micrograms/ml in adults and 20 to 25 micrograms/ml in children over 1 year of age).

For administration via Target-Controlled Infusion (TCI), the recommended dilution of remifentanil is 20 to 50 micrograms/ml.

The reconstitution and dilution of the remifentanil solution can be performed with one of the following solutions for injection:

  • water for injectable preparations,
  • injectable glucose solution 50 mg/ml (5%),
  • injectable glucose solution 50 mg/ml (5%) and sodium chloride 9 mg/ml (0.9%),
  • injectable sodium chloride solution 9 mg/ml (0.9%),
  • injectable sodium chloride solution 4.5 mg/ml (0.45%).

The dilution depends on the technical capacity of the infusion device and the patient's anticipated requirements.

This medication is compatible with lactated Ringer's solution, lactated Ringer's solution with glucose 50 mg/ml (5%), and propofol when administered through an intravenous catheter.

Dosage

Refer to the Summary of Product Characteristics for information on dosage.

Depending on the indications, dosage recommendations are provided for adults and/or children (1 to 12 years of age) and adjustments are proposed for special populations.

Overdose Treatment

Due to the very short duration of action, the potential for adverse effects due to overdose is limited to the immediate period following administration. The response to discontinuation of the medication is rapid, returning to the initial state within 10 minutes.

In the event of overdose or suspected overdose, the following protocol should be followed:

  • discontinue administration of the medication,
  • maintain an open airway,
  • initiate assisted ventilation with oxygen,
  • and establish hemodynamic stability.

If respiratory depression is associated with muscle rigidity, a neuromuscular blocker may be required to facilitate ventilation.

To maintain vascular filling, administration of certain medications (vasopressors) may be useful to correct hypotension, as well as other supportive measures.

A morphine antidote such as naloxone can be administered intravenously to treat severe respiratory depression and muscle rigidity. It is unlikely that the duration of respiratory depression after overdose will be longer than the duration of the antidote.

Stability and Storage Conditions

Remifentanilo Kern Pharma is preservative-free and for single use. Any unused material should be discarded.

Medicines should not be disposed of via wastewater or household waste.

Incompatibilities

Remifentanilo Kern Pharma should be reconstituted or diluted only with the recommended solutions for injection.

It should not be reconstituted or mixed with lactated Ringer's solution or lactated Ringer's solution with glucose 50 mg/ml (5%).

This medication should not be mixed with propofol in the same solution for intravenous administration.

It is not recommended to administer this medication through the same intravenous administration route as blood, serum, or plasma.

This medication should not be mixed with other medications prior to administration.

Online doctors for REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION

Discuss questions about REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (1061)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80
5.0 (184)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Bulat Garipov

General medicine 15 years exp.

Dr. Bulat Garipov is a radiologist with more than 15 years of experience, specializing in magnetic resonance imaging (MRI). Throughout his professional career, he has worked in leading diagnostic imaging centers, both in on-site practice and teleradiology, which has allowed him to develop a broad and versatile approach to radiology.

Over the years, he has gained solid experience in interpreting MRI studies in various areas, including:

  •  Neuroimaging
  •  Musculoskeletal system (MSK)
  •  Angiography
  •  Abdomen and pelvis
  •  Soft tissues

Additionally, Dr. Garipov is open to new collaboration opportunities in radiology and teleradiology projects. He offers his expertise in MRI, providing both first and second readings of studies, as well as advanced image interpretation, ensuring accurate and high-quality diagnostics.

You could consult Dr. Bulat Garipov in cases where accurate interpretation of MRI studies or a second expert opinion is required. His expertise is especially valuable in cases of suspected neurological conditions, back and joint pain, vascular disorders, as well as in the diagnosis of abdominal and pelvic diseases. The doctor also provides support in complex or unclear clinical situations, including the review of previously performed studies, which helps improve diagnostic accuracy and determine the optimal treatment strategy. A teleradiology format is available, allowing you to receive a professional opinion remotely.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION?
REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION?
The active ingredient in REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION is remifentanil. This information helps identify medicines with the same composition but different brand names.
Who manufactures REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION?
REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION is manufactured by Kern Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to REMIFENTANIL KERN PHARMA 5 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION?
Other medicines with the same active substance (remifentanil) include REMIFENTANIL KERN PHARMA 1 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION, REMIFENTANIL KERN PHARMA 2 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION, REMIFENTANIL NORIDEM 1 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION AND INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media